[Form 4] Jackson Financial Inc. Insider Trading Activity
Rhea-AI Filing Summary
Christopher Raub, Executive Vice President of Jackson Financial Inc. (JXN), reported acquisitions on 09/25/2025 of dividend equivalents paid in the form of restricted share units (RSUs) tied to prior equity grants. The Form 4 shows multiple non-derivative common stock entries recorded as acquisitions with reported amounts 30,261.57, 30,301.63, 30,344.99 and 30,377.49 shares following each transaction, and a derivative entry reflecting 2,815.4 RSUs underlying common stock acquired at a recorded price of $0.00. Explanations state these are dividend equivalents subject to the same terms as underlying equity grants dated March 10, 2023; September 10, 2023; March 10, 2024; March 10, 2025; and May 9, 2025. The filing was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider receipt of dividend equivalents as RSUs; disclosure is consistent with equity compensation practices.
The Form 4 documents the Executive Vice President's receipt of dividend equivalents converted into restricted share units tied to prior equity grants across multiple grant dates. This is a standard post-grant administrative event that increases the executive's reported beneficial holdings without any cash purchase. The filing provides specific share-equivalent amounts and identifies the underlying grant dates, supporting transparency in insider compensation reporting.
TL;DR: Non-material equity accruals reported; transaction values show $0.00 price, indicating dividend-equivalent issuance.
The entries list acquisitions with a recorded price of $0.00 and an explanatory note that these are dividend equivalents converted into RSUs. The Form 4 quantifies both non-derivative share-equivalents and derivative RSUs (2,815.4 RSUs), enabling investors to track dilution and insider holding changes. The disclosure appears procedural and does not evidence open-market purchases or sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 21.87 | $0.00 | -- |
| Grant/Award | Common Stock | 13.07 | $0.00 | -- |
| Grant/Award | Common Stock | 40.06 | $0.00 | -- |
| Grant/Award | Common Stock | 43.36 | $0.00 | -- |
| Grant/Award | Common Stock | 32.5 | $0.00 | -- |
Footnotes (1)
- Acquired dividend equivalents in the form of restricted share units that are subject to the same terms and conditions as the underlying equity granted to the reporting person on September 10, 2023. Acquired dividend equivalents in the form of restricted share units that are subject to the same terms and conditions as the underlying equity granted to the reporting person on March 10, 2024. Acquired dividend equivalents in the form of restricted share units that are subject to the same terms and conditions as the underlying equity granted to the reporting person on March 10, 2025. Acquired dividend equivalents in the form of restricted share units that are subject to the same terms and conditions as the underlying equity granted to the reporting person on May 9, 2025. Acquired dividend equivalents in the form of restricted share units that are subject to the same terms and conditions as the underlying equity granted to the reporting person on March 10, 2023.